Recurrent oedema associated with the co-formulation of lopinavir and ritonavir Edema recorrente associado à co-formulação de lopinavir e ritonavir

類似資料

• Toxicity for warfarine switching from lopinavir/ritonavir to dolutegravir
  著者:: Ana Pelufo-Pellicer, 等
  出版事項: (2017-03-01)
• The effect of lopinavir - ritonavir on mortality in COVID-19 pneumonia
  著者:: Muhammed Emin Demirkol, 等
  出版事項: (2024-10-01)
• COVID-19 Hastalarında Lopinavir/Ritonavir ve Favipravir Deneyimi
  著者:: Esma Eroğlu, 等
  出版事項: (2020-12-01)
• Coadministration of lopinavir/ritonavir and rifampicin in HIV and tuberculosis co-infected adults in South Africa.
  著者:: Richard A Murphy, 等
  出版事項: (2012-01-01)
• The Palatability of Lopinavir and Ritonavir Delivered by an Innovative Freeze-Dried Fast-Dissolving Tablet Formulation
  著者:: David W. Pittman, 等
  出版事項: (2018-01-01)